Case report reveals challenges in treating uveitis in lung cancer patients using antibody therapy, suggesting a need for better guidelines.
Corticosteroid treatment has proven effective for Vogt-Koyanagi-Harada-like uveitis. Currently, the optimal mode and dosage of corticosteroid therapy have not been clearly defined. Gathering more real-world cases of Vogt-Koyanagi-Harada-like uveitis associated with anti-programmed death 1 antibodies would be beneficial in developing therapeutic guidelines.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: